This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Focus on Chronic Wounds: Chronic wounds, such as diabetic ulcers and pressure ulcers, remain a significant healthcare challenge. The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Subscribe Today!
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. in 2023 but still higher than the average revenue multiple for all technology companies, which is 3.5x. What are the biggest trends likely to affect healthcaretechnology multiples in 2025?
Nelson Advisors HealthcareTechnology > Mergers, Acquisitions, Growth, Strategy, Investments [link] We work with HealthcareTechnology founders, owners and investors to assess whether they should 'Build, Buy, Partner, Invest or Sell' in order to maximise shareholder value and investment returns.
These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround.
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. We look for similar customer-oriented ethos and patient-centric mindsets in our partnerships,” said Kim Kushner, Chief Business Officer, SSI Strategy. Learn more at koneksahealth.com.
About Koneksa Koneksa is a healthcaretechnology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. We are on Twitter.
Dedicated Facilities: The new EIT Oxford campus includes over 30,000 square meters of research laboratory space, an oncology and wellness clinic, and facilities like AI GPU Supercluster Lab, Drug Design Lab, and Medical Device Lab, specifically dedicated to healthcaretechnology advancements. Visit www.nelsonadvisors.co.uk
Recent Investments NVentures has made several notable investments in healthcare startups, including: Hippocratic AI: A company focused on developing safe and effective large language models for healthcare applications. Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Why Healthcare?
About Koneksa Koneksa is a healthcaretechnology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy.
A commitment to improving healthcare: The Scottish Government has made digital health a key priority, investing heavily in infrastructure, research, and development. As the digital health sector continues to grow, Scotland is well-positioned to play a leading role in shaping the future of healthcare. Subscribe Today! Subscribe Today!
Mergers, Acquisitions, Growth and Strategy for HealthcareTechnology companies in EMEA HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Cano Health: Healthcare and wellness company that provides primary care medical services and pharmaceutical services.
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today!
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content